Welcome!

News Feed Item

Tic Disorder Global Clinical Trials Review, H2, 2014

NEW YORK, Aug. 11, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Tic Disorder Global Clinical Trials Review, H2, 2014

http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html

Tic Disorder Global Clinical Trials Review, H2, 2014

Summary

GlobalData's clinical trial report, "Tic Disorder Global Clinical Trials Review, H2, 2014" provides data on the Tic Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Tic Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Tic Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Tic Disorder 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Tic Disorder to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Unaccomplished Trials of Tic Disorder 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Tic Disorder Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Otsuka Holdings Co., Ltd. 30
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 30
Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Tasly Pharmaceuticals, Inc. 31
Clinical Trial Overview of Top Institutes / Government 32
National Institute of Neurological Disorders and Stroke 32
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 32
National Institute of Mental Health 33
Clinical Trial Overview of National Institute of Mental Health 33
Yale University 34
Clinical Trial Overview of Yale University 34
Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Clinical Trial Overview of Parkinson's Disease and Movement Disorder Center of Boca Raton 35
Shiraz University of Medical Sciences 36
Clinical Trial Overview of Shiraz University of Medical Sciences 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
New York University School of Medicine 38
Clinical Trial Overview of New York University School of Medicine 38
National Center for Research Resources 39
Clinical Trial Overview of National Center for Research Resources 39
Massachusetts General Hospital 40
Clinical Trial Overview of Massachusetts General Hospital 40
Washington University School of Medicine 41
Clinical Trial Overview of Washington University School of Medicine 41
Five Key Clinical Profiles 42
Appendix 67
Abbreviations 67
Definitions 67
Research Methodology 68
Secondary Research 68
About GlobalData 69
Contact Us 69
Disclaimer 69
Source 69

List of Tables

Tic Disorder Therapeutics, Global, Clinical Trials by Region, 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Tic Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics, Global, Terminated Clinical Trials, 2014* 24
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2014* 30
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tasly Pharmaceuticals, Inc., 2014* 31
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014* 32
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2014* 33
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 34
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Parkinson's Disease and Movement Disorder Center of Boca Raton, 2014* 35
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shiraz University of Medical Sciences, 2014* 36
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2014* 37
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by New York University School of Medicine, 2014* 38
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014* 39
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2014* 40
Tic Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Washington University School of Medicine, 2014* 41

List of Figures

Tic Disorder Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Tic Disorder Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Tic Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014* 10
Tic Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Tic Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Tic Disorder Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Tic Disorder to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Tic Disorder Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Tic Disorder to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18
Tic Disorder Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Tic Disorder Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Tic Disorder Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Tic Disorder Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Tic Disorder Therapeutics Clinical Trials, Global, by End Point Status, 2014* 23
Tic Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 25
Tic Disorder Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 26
Tic Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 27
Tic Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Tic Disorder Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 68


To order this report: Tic Disorder Global Clinical Trials Review, H2, 2014
http://www.reportlinker.com/p02280950/Tic-Disorder-Global-Clinical-Trials-Review-H2-2014.html



__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Between 2005 and 2020, data volumes will grow by a factor of 300 – enough data to stack CDs from the earth to the moon 162 times. This has come to be known as the ‘big data’ phenomenon. Unfortunately, traditional approaches to handling, storing and analyzing data aren’t adequate at this scale: they’re too costly, slow and physically cumbersome to keep up. Fortunately, in response a new breed of technology has emerged that is cheaper, faster and more scalable. Yet, in meeting these new needs they...
"We're a cybersecurity firm that specializes in engineering security solutions both at the software and hardware level. Security cannot be an after-the-fact afterthought, which is what it's become," stated Richard Blech, Chief Executive Officer at Secure Channels, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
When it comes to cloud computing, the ability to turn massive amounts of compute cores on and off on demand sounds attractive to IT staff, who need to manage peaks and valleys in user activity. With cloud bursting, the majority of the data can stay on premises while tapping into compute from public cloud providers, reducing risk and minimizing need to move large files. In his session at 18th Cloud Expo, Scott Jeschonek, Director of Product Management at Avere Systems, discussed the IT and busin...
According to Forrester Research, every business will become either a digital predator or digital prey by 2020. To avoid demise, organizations must rapidly create new sources of value in their end-to-end customer experiences. True digital predators also must break down information and process silos and extend digital transformation initiatives to empower employees with the digital resources needed to win, serve, and retain customers.
The IoT is changing the way enterprises conduct business. In his session at @ThingsExpo, Eric Hoffman, Vice President at EastBanc Technologies, discussed how businesses can gain an edge over competitors by empowering consumers to take control through IoT. He cited examples such as a Washington, D.C.-based sports club that leveraged IoT and the cloud to develop a comprehensive booking system. He also highlighted how IoT can revitalize and restore outdated business models, making them profitable ...
In his general session at 19th Cloud Expo, Manish Dixit, VP of Product and Engineering at Dice, discussed how Dice leverages data insights and tools to help both tech professionals and recruiters better understand how skills relate to each other and which skills are in high demand using interactive visualizations and salary indicator tools to maximize earning potential. Manish Dixit is VP of Product and Engineering at Dice. As the leader of the Product, Engineering and Data Sciences team at D...
SaaS companies can greatly expand revenue potential by pushing beyond their own borders. The challenge is how to do this without degrading service quality. In his session at 18th Cloud Expo, Adam Rogers, Managing Director at Anexia, discussed how IaaS providers with a global presence and both virtual and dedicated infrastructure can help companies expand their service footprint with low “go-to-market” costs.
Get deep visibility into the performance of your databases and expert advice for performance optimization and tuning. You can't get application performance without database performance. Give everyone on the team a comprehensive view of how every aspect of the system affects performance across SQL database operations, host server and OS, virtualization resources and storage I/O. Quickly find bottlenecks and troubleshoot complex problems.
"Once customers get a year into their IoT deployments, they start to realize that they may have been shortsighted in the ways they built out their deployment and the key thing I see a lot of people looking at is - how can I take equipment data, pull it back in an IoT solution and show it in a dashboard," stated Dave McCarthy, Director of Products at Bsquare Corporation, in this SYS-CON.tv interview at @ThingsExpo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
"We are the public cloud providers. We are currently providing 50% of the resources they need for doing e-commerce business in China and we are hosting about 60% of mobile gaming in China," explained Yi Zheng, CPO and VP of Engineering at CDS Global Cloud, in this SYS-CON.tv interview at 19th Cloud Expo, held November 1-3, 2016, at the Santa Clara Convention Center in Santa Clara, CA.
Predictive analytics tools monitor, report, and troubleshoot in order to make proactive decisions about the health, performance, and utilization of storage. Most enterprises combine cloud and on-premise storage, resulting in blended environments of physical, virtual, cloud, and other platforms, which justifies more sophisticated storage analytics. In his session at 18th Cloud Expo, Peter McCallum, Vice President of Datacenter Solutions at FalconStor, discussed using predictive analytics to mon...
The Internet of Things will challenge the status quo of how IT and development organizations operate. Or will it? Certainly the fog layer of IoT requires special insights about data ontology, security and transactional integrity. But the developmental challenges are the same: People, Process and Platform and how we integrate our thinking to solve complicated problems. In his session at 19th Cloud Expo, Craig Sproule, CEO of Metavine, demonstrated how to move beyond today's coding paradigm and sh...
Today we can collect lots and lots of performance data. We build beautiful dashboards and even have fancy query languages to access and transform the data. Still performance data is a secret language only a couple of people understand. The more business becomes digital the more stakeholders are interested in this data including how it relates to business. Some of these people have never used a monitoring tool before. They have a question on their mind like “How is my application doing” but no id...
@GonzalezCarmen has been ranked the Number One Influencer and @ThingsExpo has been named the Number One Brand in the “M2M 2016: Top 100 Influencers and Brands” by Onalytica. Onalytica analyzed tweets over the last 6 months mentioning the keywords M2M OR “Machine to Machine.” They then identified the top 100 most influential brands and individuals leading the discussion on Twitter.
DevOps is being widely accepted (if not fully adopted) as essential in enterprise IT. But as Enterprise DevOps gains maturity, expands scope, and increases velocity, the need for data-driven decisions across teams becomes more acute. DevOps teams in any modern business must wrangle the ‘digital exhaust’ from the delivery toolchain, "pervasive" and "cognitive" computing, APIs and services, mobile devices and applications, the Internet of Things, and now even blockchain. In this power panel at @...